John A Naslund1, Lisa A Marsch2,3,4, Gregory J McHugo3,4, Stephen J Bartels1,4,5. 1. a The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College , Lebanon , NH , USA . 2. b The Center for Technology and Behavioral Health, Dartmouth College , Lebanon , NH , USA . 3. c Psychiatric Research Center, Dartmouth College , Lebanon , NH , USA . 4. d Department of Psychiatry , and. 5. e Department of Community and Family Medicine , Geisel School of Medicine at Dartmouth , Lebanon , NH , USA.
Abstract
BACKGROUND: Serious mental illness (SMI) is one of the leading causes of disability worldwide. Emerging mobile health (mHealth) and eHealth interventions may afford opportunities for reaching this at-risk group. AIM: To review the evidence on using emerging mHealth and eHealth technologies among people with SMI. METHODS: We searched MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central, and Web of Science through July 2014. Only studies which reported outcomes for mHealth or eHealth interventions, defined as remotely delivered using mobile, online, or other devices, targeting people with schizophrenia, schizoaffective disorder, or bipolar disorder, were included. RESULTS: Forty-six studies spanning 12 countries were included. Interventions were grouped into four categories: (1) illness self-management and relapse prevention; (2) promoting adherence to medications and/or treatment; (3) psychoeducation, supporting recovery, and promoting health and wellness; and (4) symptom monitoring. The interventions were consistently found to be highly feasible and acceptable, though clinical outcomes were variable but offered insight regarding potential effectiveness. CONCLUSIONS: Our findings confirm the feasibility and acceptability of emerging mHealth and eHealth interventions among people with SMI; however, it is not possible to draw conclusions regarding effectiveness. Further rigorous investigation is warranted to establish effectiveness and cost benefit in this population.
BACKGROUND: Serious mental illness (SMI) is one of the leading causes of disability worldwide. Emerging mobile health (mHealth) and eHealth interventions may afford opportunities for reaching this at-risk group. AIM: To review the evidence on using emerging mHealth and eHealth technologies among people with SMI. METHODS: We searched MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central, and Web of Science through July 2014. Only studies which reported outcomes for mHealth or eHealth interventions, defined as remotely delivered using mobile, online, or other devices, targeting people with schizophrenia, schizoaffective disorder, or bipolar disorder, were included. RESULTS: Forty-six studies spanning 12 countries were included. Interventions were grouped into four categories: (1) illness self-management and relapse prevention; (2) promoting adherence to medications and/or treatment; (3) psychoeducation, supporting recovery, and promoting health and wellness; and (4) symptom monitoring. The interventions were consistently found to be highly feasible and acceptable, though clinical outcomes were variable but offered insight regarding potential effectiveness. CONCLUSIONS: Our findings confirm the feasibility and acceptability of emerging mHealth and eHealth interventions among people with SMI; however, it is not possible to draw conclusions regarding effectiveness. Further rigorous investigation is warranted to establish effectiveness and cost benefit in this population.
Authors: M Alvarez-Jimenez; M A Alcazar-Corcoles; C González-Blanch; S Bendall; P D McGorry; J F Gleeson Journal: Schizophr Res Date: 2014-04-17 Impact factor: 4.939
Authors: Jasper E Palmier-Claus; John Ainsworth; Matthew Machin; Cristine Barrowclough; Graham Dunn; Emma Barkus; Anne Rogers; Til Wykes; Shitij Kapur; Iain Buchan; Emma Salter; Shôn W Lewis Journal: BMC Psychiatry Date: 2012-10-17 Impact factor: 3.630
Authors: Jennifer A Manganello; Gena Gerstner; Kristen Pergolino; Yvonne Graham; David Strogatz Journal: J Racial Ethn Health Disparities Date: 2015-10-20
Authors: Kelly A Aschbrenner; John A Naslund; Thomas Grinley; John Carlo M Bienvenida; Stephen J Bartels; Mary Brunette Journal: Psychiatr Q Date: 2018-09
Authors: John A Naslund; Kelly A Aschbrenner; Lisa A Marsch; Gregory J McHugo; Stephen J Bartels Journal: Contemp Clin Trials Date: 2015-07-16 Impact factor: 2.226
Authors: Colin A Depp; Dimitri Perivoliotis; Jason Holden; Jennifer Dorr; Eric L Granholm Journal: Schizophr Bull Date: 2019-06-18 Impact factor: 9.306